Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pleural Fluid Proteomics From Patients With Pleural Infection Shows Signatures of Diverse Neutrophilic Responses: The Oxford Pleural Infection Endotyping Study (TORPIDS 2)

NCT06513689 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT06513689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06513689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pleural Fluid Proteomics From Patients With Pleural Infection Shows Signatures of Diverse Neutrophilic Responses: The Oxford Pleural Infection Endotyping Study (TORPIDS 2)
Lead sponsor
University of Oxford
Phase
Observational
Overall status
Completed
Start date
June 20, 2021
Completion date
June 20, 2024
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pleural diseases, pleural effusion, pleural empyema, pleural infection, pleural infection bacterial, pleural infections and inflammations